Selexipag

Definition: Selexipag, sold under the brand name Uptravi, is a medication developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. source: Wikipedia

ID

781378002

Name

Selexipag

Previous ID

32966711000001108

ID date

6 Feb 2023